Source briefing
Human medicines European public assessment report (EPAR): Kanjinti, trastuzumab, Date of authorisation: 16/05/2018, Revision: 12, Status: Authorised
Human medicines European public assessment report (EPAR): Kanjinti, trastuzumab, Date of authorisation: 16/05/2018, Revision: 12, Status: Authorised
Read →
Source briefing
Human medicines European public assessment report (EPAR): Usgena, ustekinumab, Date of authorisation: 17/11/2025, Revision: 2, Status: Authorised
Human medicines European public assessment report (EPAR): Usgena, ustekinumab, Date of authorisation: 17/11/2025, Revision: 2, Status: Authorised
Read →Source briefing
Vaccine Monitoring Platform (VMP) research agenda
Vaccine Monitoring Platform (VMP) research agenda
Read →Source briefing
Vaccine Monitoring Platform (VMP) research agenda – Update 2026
Vaccine Monitoring Platform (VMP) research agenda - Update 2026
Read →
Source briefing
Vaccine Monitoring Platform (VMP) research agenda
The scope of this document is to provide a thematic prioritisation and a framework to guide the choice of VMP studies to be conducted.
Read →Source briefing
Human medicines European public assessment report (EPAR): Epysqli, eculizumab, Date of authorisation: 26/05/2023, Revision: 6, Status: Authorised
Human medicines European public assessment report (EPAR): Epysqli, eculizumab, Date of authorisation: 26/05/2023, Revision: 6, Status: Authorised
Read →Source briefing
Human medicines European public assessment report (EPAR): Lacosamide Adroiq, lacosamide, Date of authorisation: 31/05/2023, Revision: 8, Status: Authorised
Human medicines European public assessment report (EPAR): Lacosamide Adroiq, lacosamide, Date of authorisation: 31/05/2023, Revision: 8, Status: Authorised
Read →Source briefing
Communicable disease threats report, 1 – 7 August 2026, week 32
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 1 - 7 August 2026, and includes updates on Ebola, chikungunya, dengue, West Nile Virus infection, Crimean-Congo haemorrhagic fever, Vibrio, respiratory virus epidemiology in the…
Read →